Psoriatic arthritis
A long-term joint condition that some people with the skin disease psoriasis get, causing painful, swollen and stiff joints. Fingers or toes can swell, and the nails may change colour or get small dents. There is no cure, but medicines can help control inflammation and pain. On average, psoriatic arthritis develops about 7 to 10 years after the beginning of skin symptoms, and it affects men and women equally.
Read more about psoriatic arthritisTrial-stage treatments and research studies you can join
Filters
- Tests nivolumab, alone or combined, for advanced cancers in people with autoimmune disorders
Tests nivolumab, alone or with other treatments, in adults with autoimmune disorders and advanced cancer.
Atlanta, United StatesAlso Baltimore, Bethesda, Birmingham, Boston, Chicago, City of Saint Peters, Columbus, Creve Coeur, …Age 18+ - Long-term Safety of Sonelokimab in Psoriatic Arthritis Patients
Tests sonelokimab, an injected drug, in adults with psoriatic arthritis who finished earlier studies.
Avondale, United StatesAlso Avon Park, Baltimore, Baytown, Charlotte, Clearwater, Duncansville, Jonesboro, Leland, …Age 18+ - Long-term study of zasocitinib for joint and skin psoriatic arthritis
Checks long-term safety of zasocitinib in adults with active psoriatic arthritis.
Baytown, United StatesAlso Bellaire, Charlotte, Denver, Fountain Valley, Grand Blanc, Hagerstown, Hialeah, Houston, …Age 18+ - Secukinumab given by infusion in children with juvenile psoriatic arthritis
Tests secukinumab infusions for safety and how the body handles them in children.
Charlotte, United StatesAlso Chicago, Cincinnati, Cleveland, El Paso, Gainesville, Loma Linda, New York, Pittsburgh, …Age 2 to 17 - Tests targeted therapies in adults with active psoriatic arthritis
Tests several targeted drugs in adults with active psoriatic arthritis, a joint disease.
Austin, United StatesAlso Avon Park, Chicago, Clearwater, Cumberland, Duncansville, Frisco, Houston, Huntington Beach, …Age 18+ - Tests DDY391 in adults with moderate to severe psoriatic arthritis
Tests DDY391 against a placebo in adults with active psoriatic arthritis.
Colleyville, United StatesAlso Corpus Christi, Duncansville, Huntington Beach, Katy, Memphis, Philadelphia, San AntonioAge 18 to 100 - Bimekizumab given by vein or by injection in psoriatic arthritis and axial spondyloarthritis
Compares bimekizumab given by vein or injection in adults with active joint disease.
Albuquerque, United StatesAlso Apple Valley, Baytown, Beckley, Bellevue, Chicago, Colleyville, Covina, Duncansville, …Age 18+ - Tests GLP-1 drugs or nutrition counseling in psoriatic arthritis with obesity and diabetes
Compares GLP-1 medicines with nutrition counseling in adults with psoriatic arthritis, obesity and diabetes.
Milwaukee, United StatesAge 18+ - Long-term safety of guselkumab in young patients with Crohn's, colitis, or juvenile arthritis
Tests long-term safety of guselkumab in children with Crohn's, colitis, or juvenile psoriatic arthritis.
Atlanta, United StatesAlso Cincinnati, Fort Worth, Indianapolis, Salt Lake CityAge 3 to 64 - Measuring guselkumab in breast milk of nursing mothers treated for psoriasis or bowel disease
Measures how much guselkumab appears in breast milk of women already receiving it.
Chapel Hill, United StatesAge 18+ - Tests deucravacitinib in children with juvenile psoriatic arthritis
Tests deucravacitinib against placebo in children aged 5 to 17 with juvenile psoriatic arthritis.
Austin, United StatesAlso Chicago, Cincinnati, Cleveland, Indianapolis, Lancaster, North New Hyde ParkAge 5 to 17 - Measures bimekizumab levels in breast milk of mothers taking it
Tests how much bimekizumab passes into breast milk in women treated for psoriasis or arthritis.
Boston, United StatesAlso Chapel Hill, Durham, Milwaukee, Santa Monica, South MiamiAge 18+ - Tests risankizumab against adalimumab in children with juvenile psoriatic arthritis
Compares risankizumab injections with adalimumab in children with juvenile psoriatic arthritis.
Austin, United StatesAlso Chapel Hill, Cleveland, Hollywood, Indianapolis, Little Rock, Miami, Minneapolis, New York, …Age 5 to 17 - Adding deucravacitinib to current treatment for hard-to-control psoriatic arthritis
Tests adding deucravacitinib to current treatment in adults with psoriatic arthritis.
Dallas, United StatesAge 18 to 65 - Aspirin and clopidogrel compared with placebo in people with psoriasis
Compares aspirin, clopidogrel and placebo for blood vessel changes in psoriasis.
New York, United StatesAge 18 to 90 - Immunosuppressant Timing Before Elective Shoulder Replacement in Rheumatology Patients
Compares stopping immunosuppressant drugs for longer versus shorter periods before shoulder replacement in rheumatic disease.
New York, United StatesAge 18+ - Studies guselkumab in psoriatic arthritis patients who also have fatty liver disease
Tests guselkumab in people with psoriatic arthritis and fatty liver disease.
San Diego, United States - Tests upadacitinib against placebo in adults with psoriatic arthritis and spine inflammation
Tests upadacitinib against placebo in adults with active psoriatic arthritis and axial spondyloarthritis.
Cleveland, United StatesAlso Philadelphia, PortlandAge 18+ - Testing an Educational Tool for Melanoma Patients With Autoimmune Disease
Tests an educational tool for adults with melanoma and autoimmune disease considering immunotherapy.
Houston, United StatesAge 18+ - Registry following children with rheumatic joint diseases over time
Collects data on children with pediatric-onset rheumatic diseases, including treatment safety.
Akron, United StatesAlso Albany, Ann Arbor, Atlanta, Augusta, Aurora, Birmingham, Boston, Burlington, …Up to age 21
Where treatment stands
There is no cure for psoriatic arthritis, but treatment can slow it down, ease pain and swelling, and protect the joints.
Approved: 34
Officially approved for this disease in the EU, the US, Switzerland or France.
Human testing stage: 6
Being tested in people. Many treatments at this stage are never approved.
Animal testing stage: 1
Worked in animals in a study published in the last 12 months. Most treatments at this stage never reach people.
Placebo: a dummy treatment without the medicine, used for comparison.
Phase 1, 2, 3: the steps of testing in people. Phase 1 checks safety, phase 3 is the last step before approval.
The EU medicines agency (EMA) and its list of medicines in the EU, US prescribing labels (DailyMed, openFDA), the Swiss medicines register (Swissmedic), the French medicines database (ANSM) and the Health Canada drug database, checked on 11 November 2026. Every medicine links to its own official text.
A computer made this list from the official texts: it kept only medicines whose own approval text names the disease, wrote "Who it is for" from that text and checked it against the text a second time. People have not reviewed it yet.
The trials: ClinicalTrials.gov and the EU trials register, as copied into our trial database, checked on 12 November 2026. Every treatment in trials links to its own trial records; the texts are written by AI from them and checked against them by a second AI. People have not reviewed them yet. Placebo, standard medicines used for comparison and procedures are left out.
Phase 3 trials are listed from every country; only some phase 2 trials are listed, so 11 other open phase 2 trials are not listed.
Animal and lab research: studies listed in PubMed and published in the 12 months before 12 November 2026, found by a search for psoriatic arthritis. AI chose the treatments from the study summaries and wrote the texts; a second AI checked each one against its study summary. People have not reviewed them yet. Treatments already in the approved or human testing lists are left out. A result in animals or cells does not show that a treatment works in people.
Not medical advice. Talk to your doctor before you change any treatment.
The approval records under a medicine come from Drugs@FDA and the FDA labels (openFDA) and from the EU medicines agency’s medicine data, with its orphan designations, checked on 13 Nov 2026. A date is the medicine’s first approval, for any use; the quoted text is its approved use as written today.
Support organisations
Patient organisations and helplines in United States, for you and your family.
Psoriatic arthritis organisations in United States
- Arthritis Foundation
The largest US nonprofit dedicated to the prevention, control and cure of arthritis, with support and resources for RA, PsA, axial SpA and lupus.
- CreakyJoints
Patient community for people with arthritis and rheumatic disease (Global Healthy Living Foundation): support, education, advocacy and research.
- National Psoriasis Foundation
US nonprofit helping people with psoriasis and psoriatic arthritis get treatment, with patient navigation, education and research.
General support in United States
- 988 Suicide & Crisis Lifeline
US national 24/7 free and confidential lifeline for anyone in suicidal crisis or emotional distress, reachable by calling or texting 988 or by chat.
- MedlinePlus
Free, easy-to-read health information service of the US National Library of Medicine (NIH) on diseases, conditions, drugs and wellness.
International organisations
Offer tissue or data
There are three ways to help research move faster.
Treatments approved outside the EU
Medicines for psoriatic arthritis approved in the US or Japan that are not approved in the EU.
Checked on 11 Nov 2026 in the official lists of the US (FDA), Japan (PMDA, approvals since April 2004) and the EU (EMA). 7 uncertain matches are left out.
Your health insurer may pay part of the cost, sometimes all of it. This depends on your insurer, your plan and the country, so always ask your insurer before you go. For planned care in the EU, the EEA and Switzerland, ask about form S2.
“Miracle cure” fact checker
Social media spreads misinformation. Paste what you read here, and we'll tell you whether there is scientific evidence behind it.
What you paste is checked with AI (Anthropic, USA) and is not stored. Please leave out names and other personal details.
Before you pay for anything, ask three things
- Is there a published study in people?
- Can I have the full price in writing?
- What does my doctor say?
“Cures” others already fact-checked
- Omega-3 fatty acids (fish oil) & Psoriatic arthritis
- Curcumin (turmeric) & Psoriatic arthritis
- Stem cell treatment & Psoriatic arthritis
- CBD (cannabidiol) & Psoriatic arthritis
About psoriatic arthritis
Sources: NHS, NIAMS, MedlinePlus
A long-term joint condition that some people with the skin disease psoriasis get, causing painful, swollen and stiff joints. Fingers or toes can swell, and the nails may change colour or get small dents. There is no cure, but medicines can help control inflammation and pain. On average, psoriatic arthritis develops about 7 to 10 years after the beginning of skin symptoms, and it affects men and women equally.
What is it?
Psoriatic arthritis is a long-term condition that causes painful, swollen and stiff joints. It affects some people who have psoriasis, a skin condition. Like psoriasis, psoriatic arthritis is caused by the immune system attacking healthy tissue. It is an inflammatory condition of the joints and the places where tendons and ligaments attach to bones. Why some people with psoriasis get it and others do not is not clear.
It is most common in adults, and men and women get it equally often. Most people already have psoriasis, and on average psoriatic arthritis develops about 7 to 10 years after the beginning of skin symptoms, but a small group have joint pain before the skin rash. Many people with it have relatives with the disease. Obesity and having severe psoriasis appear to be associated with a higher risk of arthritis among people with psoriasis.
The first signs
It is often mild, but can sometimes be serious and affect many joints.
- pain, swelling and stiffness in one or more joints, often worse in the morning;
- a whole finger or toe that swells up;
- nails that change colour or get small dents or pits;
- tenderness where tendons or ligaments attach to bones, commonly at the back of the heel and the sole of the foot;
- feeling drained of energy.
A red, painful eye can be a sign of eye inflammation (uveitis), which needs treatment quickly to protect your sight.
How doctors find out
Symptoms differ a lot from person to person, which can make the disease hard to diagnose. If the doctor thinks you may have psoriatic arthritis, they will refer you to a specialist (rheumatologist). Tests can include blood tests, a test of fluid taken from a swollen joint, and X-rays, ultrasound or MRI scans.
Current treatment
NSAIDs can help with mild symptoms, steroid injections into a joint ease the pain, DMARDs are used for moderate to severe symptoms, and biological treatments can be used if DMARDs do not help.
Will it get worse?
It is often mild, but it can sometimes be serious and affect many joints. Psoriatic arthritis is a progressive inflammatory condition, and treatments can slow its progression. Starting treatment early is linked to better results and less damage: treatment can slow the disease, ease the pain and protect the joints. Some people also get eye inflammation or bowel inflammation.
Medicines: what helps, and what to watch for
Medicines are the main treatment. Non-steroidal anti-inflammatory drugs (NSAIDs) come as tablets, creams or gels and can help with mild symptoms. A steroid injection into a joint can ease pain. Disease-modifying anti-rheumatic drugs (DMARDs) are used for moderate to severe symptoms. Biological treatments, usually given by injection, can be used if DMARDs do not help.
Good to know:
- DMARDs can take several months to work, so keep taking them even if you do not feel better straight away;
Exercise and therapy help too
- exercise regularly: low impact exercises like swimming, walking and yoga can help strengthen and protect your joints; symptoms may improve with exercise;
- a physiotherapist gives you exercises to strengthen your joints and help prevent damage;
- an occupational therapist advises on changes and equipment at home and at work;
- if you are overweight, losing weight takes pressure off your joints;
Surgery, for some people
In rare cases, surgery is used to repair or replace a damaged joint.
Is there a cure?
No. There is no cure for psoriatic arthritis. Better understanding of the disease has improved treatment, which can slow it down and protect the joints.
Sources
Written in plain words by Frontlight from these pages: